These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16775879)

  • 1. Depression--augmentation or switch after initial SSRI treatment.
    Williams SC
    N Engl J Med; 2006 Jun; 354(24):2611-3; author reply 2611-3. PubMed ID: 16775879
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication augmentation after the failure of SSRIs for depression.
    Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
    N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation strategies to increase antidepressant efficacy.
    Shelton RC
    J Clin Psychiatry; 2007; 68 Suppl 10():18-22. PubMed ID: 17900205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
    Thase ME; Friedman ES; Biggs MM; Wisniewski SR; Trivedi MH; Luther JF; Fava M; Nierenberg AA; McGrath PJ; Warden D; Niederehe G; Hollon SD; Rush AJ
    Am J Psychiatry; 2007 May; 164(5):739-52. PubMed ID: 17475733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression.
    Lam RW; Hossie H; Solomons K; Yatham LN
    J Clin Psychiatry; 2004 Mar; 65(3):337-40. PubMed ID: 15096072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
    Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
    J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing thai economic model to study cost-effectiveness of switching to bupropion compared to combination with bupropion after the failure of an SSRI for major depressive disorder.
    Leelahanaj T
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S35-42. PubMed ID: 21284135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.
    Landén M; Björling G; Agren H; Fahlén T
    J Clin Psychiatry; 1998 Dec; 59(12):664-8. PubMed ID: 9921700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
    Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
    J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study.
    Maron E; Eller T; Vasar V; Nutt DJ
    J Clin Psychiatry; 2009 Jul; 70(7):1054-6. PubMed ID: 19653982
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
    Bech P; Fava M; Trivedi MH; Wisniewski SR; Rush AJ
    Acta Psychiatr Scand; 2012 Apr; 125(4):342-8. PubMed ID: 22077211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
    N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.
    Landén M; Eriksson E; Agren H; Fahlén T
    J Clin Psychopharmacol; 1999 Jun; 19(3):268-71. PubMed ID: 10350034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Gaynes BN; Farley JF; Dusetzina SB; Ellis AR; Hansen RA; Miller WC; Stürmer T
    Depress Anxiety; 2011 Nov; 28(11):989-98. PubMed ID: 21898717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
    Landén M; Högberg P; Thase ME
    J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion: a review of its use in the management of major depressive disorder.
    Dhillon S; Yang LP; Curran MP
    Drugs; 2008; 68(5):653-89. PubMed ID: 18370448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.